Xynor® (Ornidazole) is a 5-nitroimidazole derivative. It is an anti-microbial agent. It is used in the treatment of susceptible protozoal infections and in the treatment and prophylaxis of anaerobic bacterial infections. The antimicrobial activity of Ornidazole is due to the reduction of the nitro group to a more reactive amine that attacks microbial DNA, brings about loss of helical structure of DNA and subsequent DNA breakage thus inhibiting further synthesis and causing degradation of existing DNA.Xyno® r (Ornidazole) is indicated for: A. Amoebiasis (Intestinal and hepatic) B. Giardiasis C. Trichomoniasis D. Bacterial Vaginosis E. Treatment of susceptible anaerobic infections.
Xynor 500mg Tablet
Adult: 1.5 g as a single daily dose for 3 days. Alternatively for patients >60 kg: 1 g bid for 3 days.
Child: 40 mg/kg daily.
Adult: 1.5 g as a single daily dose or 0.5 g bid for 5 days. Treat sexual partners concomitantly.
Child: 25 mg/kg as a single dose.
Adult: 0.5 g bid for 5-10 days.
Child: 25 mg/kg as a single daily dose for 5-10 days.
Adult: 1-1.5 g as a single daily dose for 1-2 days.
Child: 30-40 mg/kg daily.